2013
DOI: 10.1212/wnl.0b013e3182872c54
|View full text |Cite
|
Sign up to set email alerts
|

Somatosensation assessment using the NIH Toolbox

Abstract: Touch sensation is one element of sensory function. As such, somatosensation is one of the sensory domains included in the NIH Toolbox, which is an assessment battery for measuring a range of human functions including emotional health, sensation, cognition, and motor function. We evaluated a variety of methods for inclusion in the NIH Toolbox main battery. In a convenience sample of 409 participants, we evaluated aspects of kinesthesia, pain, and tactile discrimination. We present results on these measures acr… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
60
0

Year Published

2013
2013
2023
2023

Publication Types

Select...
9
1

Relationship

1
9

Authors

Journals

citations
Cited by 50 publications
(61 citation statements)
references
References 32 publications
0
60
0
Order By: Relevance
“…Stüve et al 17 reported on a small group of patients (n = 23) followed with immunologic, clinical, and MRI evaluations during 14 months after discontinuation of NZ that the effect of NZ decreased over a 3- to 6-month period. Similarly, a North American study 18 based on 175 patients with MS treated with NZ for at least 1 year showed that gadolinium-enhancing lesions were first detected 3 months after the last NZ infusion, and authors 19 reported in a small group of patients (n = 32) a reactivation of disease activity between 3 and 9 months after NZ interruption, independently of an alternative treatment prescribed.…”
Section: Discussionmentioning
confidence: 92%
“…Stüve et al 17 reported on a small group of patients (n = 23) followed with immunologic, clinical, and MRI evaluations during 14 months after discontinuation of NZ that the effect of NZ decreased over a 3- to 6-month period. Similarly, a North American study 18 based on 175 patients with MS treated with NZ for at least 1 year showed that gadolinium-enhancing lesions were first detected 3 months after the last NZ infusion, and authors 19 reported in a small group of patients (n = 32) a reactivation of disease activity between 3 and 9 months after NZ interruption, independently of an alternative treatment prescribed.…”
Section: Discussionmentioning
confidence: 92%
“…37, 38 It can detect differences in kinesthetic performance between people with mildmoderate hemiparesis post-stroke and age-matched controls. 39 A cut point of >6.5 cm error was used to indicate impairment in kinesthetic sense.…”
Section: Discussionmentioning
confidence: 99%
“…After review and initial testing (see Dunn et al, 2013, for details), we included measures of tactile detection and discrimination, proprioception, and haptic object recognition.…”
Section: Designmentioning
confidence: 99%